Cargando…
Ginsenoside Rb1 regulates prefrontal cortical GABAergic transmission in MPTP-treated mice
Parkinson’s disease (PD) is a common neurodegenerative disease, featured by motor deficits and non-motor symptoms such as cognitive impairment, and malfunction of gamma-aminobutyric acid (GABA) mediated inhibitory transmission plays an important role in PD pathogenesis. The ginsenoside Rb1 molecule,...
Autores principales: | Liu, Yan, Zong, Xiaodan, Huang, Jie, Guan, Yanfei, Li, Yuanquan, Du, Ting, Liu, Keyin, Kang, Xinpan, Dou, Chunyan, Sun, Xiangdong, Wu, Renhua, Wen, Lei, Zhang, Yunlong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682523/ https://www.ncbi.nlm.nih.gov/pubmed/31314744 http://dx.doi.org/10.18632/aging.102095 |
Ejemplares similares
-
Ginsenoside Rb1 prevents MPTP-induced changes in hippocampal memory via regulation of the α-synuclein/PSD-95 pathway
por: Qu, Shaogang, et al.
Publicado: (2019) -
Neuroprotective effects of ginsenoside Rb1 on hippocampal neuronal injury and neurite outgrowth
por: Liu, Juan, et al.
Publicado: (2014) -
Ginsenoside Rg1 modulates medial prefrontal cortical firing and suppresses the hippocampo-medial prefrontal cortical long-term potentiation
por: Ghaeminia, Mehdy, et al.
Publicado: (2018) -
Antiobesity and Antihyperglycemic Effects of Ginsenoside Rb1 in Rats
por: Xiong, Ye, et al.
Publicado: (2010) -
Effects of Ginsenoside Rb(1) on Skin Changes
por: Kimura, Yoshiyuki, et al.
Publicado: (2012)